How Does Keytruda Work for RCC? Some cancer cells have what are called checkpoint proteins known as PD-L1 on their cell surface. Some immune cells in our bodies called T cells have proteins on ...

Your doctor may adjust your dosage. The active ingredient in Keytruda is pembrolizumab. (An active ingredient is what makes a drug work.) Keytruda belongs to a group of drugs called monoclonal ...

Merck is particularly exposed to the tariff threat, as much of its production of Keytruda takes place at facilities in ...

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares ...

Combining Trodelvy with Keytruda and pushing it into the frontline setting could “potentially double” the ADC’s market in ...

Already approved in a host of other cancer indications, including the lucrative first-line lung cancer use, Keytruda works by targeting the cellular pathway known as PD-1/PD-L1. The FDA approved ...

Despite a proven survival benefit, the addition of pembrolizumab (Keytruda) to chemoradiotherapy ... from VIVIO Health ...

South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda. The PD-1 checkpoint inhibitor cancer treatment is fast ...

Merck (MRK) is reportedly looking to expand its U.S. manufacturing presence with a $1 billion facility in Delaware, becoming ...

You can reach Jonathan on Signal at jwosen.27. Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy ...

Merck recently announced promising results from its Phase 3 KEYNOTE-689 trial of KEYTRUDA, presented at the AACR Annual Meeting, which seems likely to have bolstered investor confidence ...